It is characterized by hyperactivation of the IL-1/IL-6 signaling pathways, increased levels of endogenous Toll-like receptor ligands such as S100 proteins, and a heightened susceptibility to macrophage activation syndrome (MAS) (4, 5). This evidence concerns the gene IL6 and macrophage activation syndrome.